logo conference-reports

Hasil Konferensi

Educational funding by logo MSD Oncology

ESMO-IO 2019 – How to apply the latest immunotherapies for NSCLC in treating patients at both ends of the spectrum

The newest immunotherapies for treating both late stage and neoadjuvant patients are exciting but should be taken with some caution.